ACELRX PHARMACEUTICALS INC (28) | Uncategorized (6)

Recent Contracts

Promotion Agreement among the Registrant, La Jolla Pharmaceutical Company and Tetraphase Pharmaceuticals, Inc., effective September 30, 2020 (Filed With SEC on November 5, 2020)
Form of Revised CVR Agreement (Filed With SEC on May 29, 2020)
Amendment No. 1 to Co-Promotion Agreement, dated as of May 26, 2020, by and between the Registrant and Tetraphase (Filed With SEC on May 29, 2020)
Form of Revised CVR Agreement (Filed With SEC on May 27, 2020)
Agreement between the Registrant and SpecGX, LLC, dated June 16, 2017 (Filed With SEC on November 7, 2019)
Amendment to Agreement between the Registrant and SpecGX, LLC, dated September 23, 2019 (Filed With SEC on November 7, 2019)